Novel bioassay predicts cancer patients' response to immunotherapy
A team of researchers from Ben-Gurion University of the Negev (BGU) has developed a groundbreaking bio-sensing technology that predicts the response of cancer patients to anti-PD1, an immune checkpoint inhibitor (ICI) therapy, ...
May 31, 2023
0
45